Science to practice: Will improved assessment of response to antiangiogenic therapies be achieved with contrast-enhanced gray-scale US?
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 16793969.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
McCarville et al have used gray-scale contrast-enhanced low-mechanical-index, and thus non-bubble-destructive, continuous US to quantitate tumor blood flow in mouse tumors engineered to simulate antiangiogenic therapy. They have shown that contrast-enhanced gray-scale US, unlike power or color Doppler US performed without contrast enhancement, is better able to depict and distinguish microvascular flow in subcutaneously implanted mouse tumors possessing different vascular phenotypes.
Medical subject headings
- Angiogenesis Inhibitors
- Contrast Media
- Neoplasms
- Neovascularization, Pathologic